Is BPC-157 Legal in the UK and UAE?
BPC-157 is not a controlled substance in the UK and is lawful to buy and possess as a research reagent. It has no MHRA marketing authorisation, so selling or supplying it for human use is unlawful under the Human Medicines Regulations 2012.
BPC-157 is not scheduled as a controlled substance in the UAE. It can be lawfully supplied as a research-use-only reagent; it is not licensed by MOHAP/DHA for human administration.
UK detail
BPC-157 does not appear on the Misuse of Drugs Act 1971 schedules or the Psychoactive Substances Act 2016 list, so purchase and possession for genuine research purposes is not a criminal offence. The separate question is medicinal-product status: it has never been granted a UK marketing authorisation, so any sale, marketing, or supply that presents it for human treatment or enhancement falls under Regulation 46 of the Human Medicines Regulations 2012 and is an offence. A supplier selling it strictly as a laboratory reagent, with no dosing or health-outcome claims, is operating within the standard RUO framing that UK research-chemical law recognises.
UAE detail
The UAE does not list BPC-157 under its controlled-substance schedules. As with all research-use compounds in the Emirates, the distinction that matters is channel: DHA/MOHAP-licensed clinical supply versus the research-reagent channel that PepcoLab and comparable suppliers operate in, which carries no human-use authorisation. Buyers should expect UAE customs to inspect health-adjacent shipments, and sourcing from UAE-held stock rather than overseas drop-shipping reduces that friction considerably.
This is a general overview, not legal advice, and law in this area can change. For a specific situation, consult a solicitor with life-sciences regulatory experience (UK) or MOHAP/DHA directly (UAE). See our full UK compliance guide and UAE compliance guide for the full legal framework this page summarises.